Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort-Reference-Cited by-同舟云学术

Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort

Published:2018-02 Issue: Volume:192 Page:357-363
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

Kline Emily R.,Seidman Larry J.,Cornblatt Barbara A.,Woodberry Kristen A.,Bryant Caitlin,Bearden Carrie E.,Cadenhead Kristin S.,Cannon Tyrone D.,Mathalon Daniel H.,McGlashan Thomas H.,Perkins Diana O.,Tsuang Ming T.,Walker Elaine F.,Woods Scott W.,Addington Jean

Funder

National Institute of Mental Health

Commonwealth of Massachusetts

National Center for Research Resources to Harvard University

Beth Israel Deaconess Medical Center

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference49 articles.

1. Assessing depression in schizophrenia: the Calgary Depression Scale;Addington;Br. J. Psychiatry,2007

2. North American Prodrome Longitudinal Study (NAPLS 2): the prodromal symptoms;Addington;J. Nerv. Ment. Dis.,2015